Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Pharmacovigilance (PV) and Drug Safety Software Market to 2027 - Global Analysis and Forecasts By Software Type ( Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software ); Delivery Mode ( On-premise, Cloud-based ); End User ( Pharmaceutical and Biotech Companies, Contract Research Organizations (CROs), Business Process Outsourcing (BPO) Firms, Pharmacovigilance Service Providers ),and Geography

  • THE3276296
  • 135 Pages
  • September 2019
  • Pharmaceuticals
Download Sample    Get Discount   
 
Pharmacovigilance (PV) And Drug Safety Software Market to 2027 – Global Analysis and Forecasts by Software Type, Delivery Mode, End User, and Geography

The global pharmacovigilance (PV) and drug safety software market is expected to reach US$ 262.02 Mn in 2027 from US$ 151.07 Mn in 2018. The pharmacovigilance (PV) and drug safety software market is estimated to grow with a CAGR of 6.4% from 2019-2027.

The market is driven by factors such as, rising incidences of adverse drug reactions (ADRs) and globalization of pharmacovigilance. However, expensive technology may limit the growth of the market to a certain extent.

The pharmacovigilance (PV) and drug safety software are used to recognize the cause of drug withdrawal and helps to inhibit unnecessary future events. These software are beneficial to those involved in drug making process like clinical research organization and pharmaceutical companies. These software help companies to manage huge data generated due to adverse drug reaction events. Help to maintain data for regulatory inspection and approval. These software lets global information to be shared rapidly and economically.

Though there are many advantages of pharmacovigilance (PV) and drug safety software the software deployment cost is expensive. Large pharma companies having good infrastructure for pharmacovigilance process in house prefer for on-premise. These require huge capital upfront. Hence, high price for installation of pharmacovigilance (PV) and drug safety software is anticipated to hinder the growth of market.

Global pharmacovigilance (PV) and drug safety software market was segmented by software type, delivery mode and end user. The software type was segmented as fully integrated software, adverse event reporting software, drug safety audits software, and issue tracking software. By delivery mode it is categorized in on-premise and cloud based. By end user contract research organizations (CRO’s), pharmaceutical and biotech companies, business process outsourcing.

Some of the major primary and secondary sources included in the report are, Drug Safety and Effectiveness Network, European Medicines Agency, Food and Drug Administration, National Adverse Drug Event Monitoring Centre, National Center for Biotechnology Information, Pharmacovigilance Program of India, World Health Organization, Canadian Institutes of Health Research, Indian Council of Medical Research, Federation of Pharmaceutical Industries and Associations among others.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Pharmacovigilance (PV) and Drug Safety Software Market – By Software Type

1.3.2 Global Pharmacovigilance (PV) and Drug Safety Software Market – By Delivery Mode

1.3.3 Global Pharmacovigilance (PV) and Drug Safety Software Market – By End User

1.3.4 Global Pharmacovigilance (PV) and Drug Safety Software Market – By Geography

2. Global Pharmacovigilance (PV) and Drug Safety Software Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Pharmacovigilance (PV) and Drug Safety Software Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East & Africa PEST Analysis

4.2.5 South & Central America PEST Analysis

4.3 Expert Opinions

5. Global Pharmacovigilance (PV) and Drug Safety Software Market – Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Rising Incidences Of Adverse Drug Reactions (ADRs

5.1.2 Globalization Of Pharmacovigilance

5.2 Key Market Restraints

5.2.1 Expensive Technology

5.3 Key Market Opportunities

5.3.1 Growth Opportunities in Developing Countries

5.4 Future Trends

5.4.1 Artificial Intelligence In Pharmacovigilance

5.5 Impact Analysis

6. Pharmacovigilance (PV) and Drug Safety Software Market – Global Analysis

6.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Revenue Forecasts And Analysis

6.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Geography - Forecasts And Analysis

6.3 Performance of Key Players

7. Global Pharmacovigilance (PV) And Drug Safety Software Analysis– by Software Type

7.1 Overview

7.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Product & Services 2018 & 2027 (%)

7.3 Adverse Event Reporting Software Market

7.3.1 Overview

7.3.2 Global Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.4 Drug Safety Audits Software

7.4.1 Overview

7.4.2 Global Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.5 Issue Tracking Software

7.5.1 Overview

7.5.2 Global Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)

7.6 Fully Integrated Software

7.6.1 Overview

7.6.2 Global Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)

8. Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis– by Delivery Mode

8.1 Overview

8.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Delivery Mode 2018 & 2027 (%)

8.3 On-premise Market

8.3.1 Overview

8.3.2 Global On-premise Market Revenue and Forecasts to 2027 (US$ Mn)

8.4 Cloud- Based Market

8.4.1 Overview

8.4.2 Global Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)

9. Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis– by End User

9.1 Overview

9.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By End User

2018 & 2027 (%)

9.3 Pharmaceutical and Biotech Companies Market

9.3.1 Overview

9.3.2 Global Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4 Contract Research Organizations (CROs) Market

9.4.1.1 Overview

9.4.1.2 Global Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 Business Process Outsourcing (BPO) Firms Market

9.5.1 Overview

9.5.2 Global Business Process Outsourcing (BPO) Firms Market Revenue and Forecasts to 2027 (US$ Mn)

10. Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027

10.1.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.1.2.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.2.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.3 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

10.1.4 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.5 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.6 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.1.6.1 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.6.2 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.7 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.1 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.1.8.1 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.8.2 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.1.9 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.9.1 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.10 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.1.10.1 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.1.10.2 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027

10.2.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.2.3 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.2.3.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.2.3.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.2.4 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

10.2.5 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.6 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.7 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.2.7.1 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.2.7.2 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.2.8 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.8.1 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.2.9.1 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.2.9.2 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.2.9.3 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.10 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.11 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.2.11.1 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.2.11.2 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.2.12 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.12.1 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.13 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.2.13.1 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.2.13.2 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.2.14 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.15 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.16 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.2.16.1 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.2.16.2 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.3 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027

10.3.1 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.2 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.3.2.1 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.3.2.2 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.3.3 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

10.3.4 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.5 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.6 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.3.6.1 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.3.6.2 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.3.6.3 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.7 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.8 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.3.8.1 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.3.8.2 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.3.9 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.10 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.11 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.3.11.1 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.3.11.2 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.3.12 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.13 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.14 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.3.14.1 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.3.14.2 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.3.15 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.16 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.17 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.3.17.1 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.3.17.2 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.4 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027

10.4.1 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.2 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.4.2.1 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.4.2.2 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.4.3 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

10.4.4 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.5 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.6 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.4.6.1 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.4.6.2 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.4.7 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.7.1 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.8 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.4.8.1 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.4.8.2 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.4.9 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.10 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.11 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.4.11.1 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.4.11.2 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.5 South And Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027

10.5.1 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.2 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.5.3 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.5.3.1 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.5.3.2 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.5.4 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)

10.5.5 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.6 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.7 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.5.7.1 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.5.7.2 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10.5.8 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.9 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.10 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

10.5.10.1 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

10.5.10.2 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

11. Pharmacovigilance (PV) and Drug Safety Software Market –Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-2019

11.3 Organic Developments

11.3.1 Overview

11.3.2 Organic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-2019

11.4 Inorganic Developments

11.4.1 Overview

11.4.2 Inorganic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-2019

12. Pharmacovigilance (PV) and Drug Safety Software Market–Key Company Profiles

12.1 AB Cube

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Financial Overview

12.1.4 Product Portfolio

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 UNITED BIOSOURCE LLC

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Financial Overview

12.2.4 Product Portfolio

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 ArisGlobal LLC

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Financial Overview

12.3.4 Product Portfolio

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Sparta Systems

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Financial Overview

12.4.4 Product Portfolio

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Oracle

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Financial Overview

12.5.4 Product Portfolio

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Sarjen Systems Pvt. Ltd

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Financial Overview

12.6.4 Product Portfolio

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 EXTEDO

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Financial Overview

12.7.4 Product Portfolio

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 ENNOV

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Financial Overview

12.8.4 Product Portfolio

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Maxapplication

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Financial Overview

12.9.4 Product Portfolio

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Online Business Applications, Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Financial Overview

12.10.4 Product Portfolio

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary Of Terms

LIST OF TABLES

Table 1. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 2. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 3. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 4. US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 5. US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 6. US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 7. Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 8. Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 9. Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 10. Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 11. Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 12. Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 13. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 14. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 15. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 16. UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 17. UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 18. UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 19. Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 20. Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 21. Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 22. France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 23. France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 24. France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 25. Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 26. Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 27. Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 28. Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 29. Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 30. Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 31. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 32. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 33. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 34. Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 35. Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 36. Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 37. China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 38. China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 39. China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 40. India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 41. India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 42. India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 43. South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 44. South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 45. South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 46. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 47. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 48. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 49. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 50. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 51. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 52. UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 53. UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 54. UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 55. Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 56. Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 57. Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 58. South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 59. South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 60. South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 61. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 62. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 63. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 64. Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 65. Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 66. Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 67. Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)

Table 68. Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)

Table 69. Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

Table 70. Recent Organic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market

Table 71. Recent Inorganic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market

Table 72. Glossary of Terms, Pharmacovigilance (PV) and Drug Safety Software Market

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research